What is Bone Marrow Therapy?
Bone Marrow Therapy is one of two common approaches to non-surgical joint pain treatment at Williams Integracare. Though being comparable to our Platelet Rich Plasma procedures, Bone Marrow Therapy is a stronger treatment option that often requires less repeat visits.
Every cell in our body first began as a Mesenchymal Stem Cell (MSC), and through the process of differentiation, grew and changed into its ultimate form. MSC’s are “undifferentiated,” meaning they still have the potential to grow into any cell type in the body. They are located throughout the body in almost every organ and tissue, and can change into any healthy cell in our body.
Common Areas Treated with Bone Marrow Harvest Therapy
Capabilities of MSC’s
MSC’s travel to sites of injury by cell signals that attract them. Once they reach where they need to go, they dock and start repairing the injury/disease by releasing cytokines, chemokines, and growth factors that signal your immune system to start injury repair. There are greater than 300,000 peer-reviewed scientific publications on Pubmed.gov, discussing positive outcomes following the use of Bone Marrow Therapy.
The Use of Bone Marrow Therapy in Orthopedics
Conditions that have the ability to be treated with Bone Marrow Therapy
- Osteoarthritis of the joints including hip, knee, ankle, wrist and shoulder.
- Rotator cuff tears
- Labral tears of hip or shoulder
- Meniscus tears of knee
- Spine disorders, including sciatica and degenerative disc disease
- Tennis elbow/Golfers elbow
- Plantar fasciitis
- Other ligament or tendon tears
- Muscle injuries.
- Fracture repair
- Safety and Complications Reporting on the Re-implantation of Culture-Expanded MSCs using Autologous Platelet Lysate Technique (source)
- Articular cartilage regeneration with autologous peripheral MSCs versus hyaluronic acid: a randomized controlled trial (source)
- Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous MSCs (source)
- Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study (source)